I totally agree.
This is why I am interested in how this Valens deal will effect Oil sales in the short to medium term.
Trials and results are still some time off. But if they go to plan, we will be in a sweet spot.
I see that a US company is now allowed to sell medical cannabis for OSA. But, it has no clinically proven supportive documentation. Owning IP and having a clinically proven product, with the market in its infancy, is where we want to be. it is the difference maker.
We just need to sit back and wait.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-292
-
- There are more pages in this discussion • 19,585 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online